NOS1 and metabolic syndrome: Preliminary results of our group demonstrated that ob−/ob− mice with metabolic syndrome have increased expression of mtNOS and high mitochondrial NO yield and that mitochondrial inhibition is released by NOS inhibitors or by leptin infusion, both decreasing NO yield in the organelles [32].